About this episode
A Northwestern Medicine study published in Nature Medicine, used a new technique called spatial transcriptomics to examine the brain's response to Alzheimer's therapies, revealing new molecular targets that could enhance the effectiveness of current therapies and not just slow the disease, but potentially improve patient outcomes.
David Gate, PhD, assistant professor of Neurology in the Ken and Ruth Davee Department of Neurology and director of the Abrams Research Center on Neurogenomics, led this research.
Get every episode summarized
Each time Breakthroughs publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Breakthroughs
Improving Testing and Diagnosis of Hepatitis C with Claudia Hawkins, MD, MPH
Breakthroughs
Decoding Long COVID's Impact on the Brain with Igor Koralnik, MD
Breakthroughs
Improving Imaging of the Spinal Cord with Molly Bright, DPhil
Breakthroughs
New Paths for Diagnosing and Treating Lyme Disease with Brandon Jutras, PhD
Breakthroughs